FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2280772307> ?p ?o ?g. }

• W2280772307 endingPage "41" @default.
• W2280772307 startingPage "41" @default.
• W2280772307 abstract "In vitro study of RRS HA injectable mesotherapy/biorevitalization product on human skin fibroblasts and its clinical utilization Pierre-Antoine Deglesne,* Rodrigo Arroyo,* Evgeniya Ranneva, Philippe Deprez, Research and Development, Skin Tech Pharma Group, Castelló d'Empúries, Spain, *These authors contributed equally to this work Abstract: Mesotherapy/biorevitalization with hyaluronic acid (HA) is a treatment approach currently used for skin rejuvenation. Various products with a wide range of polycomponent formulations are available on the market. Most of these formulations contain noncross-linked HA in combination with a biorevitalization cocktail, formed by various amounts of vitamins, minerals, amino acids, nucleotides, coenzymes, and antioxidants. Although ingredients are very similar among the different products, in vitro and clinical effects may vary substantially. There is a real need for better characterization of these products in terms of their action on human skin or in vitro skin models. In this study, we analyzed the effect of the RRS® (Repairs, Refills, Stimulates) HA injectable medical device on human skin fibroblasts in vitro. Skin fibroblast viability and its capacity to induce the production of key extracellular matrix were evaluated in the presence of different concentrations of RRS HA injectable. Viability was evaluated through colorimetric MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay, and key extracellular matrix genes, type I collagen and elastin, were quantified by quantitative polymerase chain reaction. Results demonstrated that RRS HA injectable could promote human skin fibroblast viability (+15%) and increase fibroblast gene expression of type I collagen and elastin by 9.7-fold and 14-fold in vitro, respectively. These results demonstrate that mesotherapy/biorevitalization products can, at least in vitro, effectively modulate human skin fibroblasts.Keywords: mesotherapy, medical device, RRS, collagen, elastin, extracellular matrix" @default.
• W2280772307 created "2016-06-24" @default.
• W2280772307 creator A5047924703 @default.
• W2280772307 creator A5073974786 @default.
• W2280772307 creator A5077591603 @default.
• W2280772307 creator A5090532833 @default.
• W2280772307 date "2016-02-01" @default.
• W2280772307 modified "2023-10-12" @default.
• W2280772307 title "In vitro study of RRS HA injectable mesotherapy/biorevitalization product on human skin fibroblasts and its clinical utilization" @default.
• W2280772307 cites W1517086839 @default.
• W2280772307 cites W1526638402 @default.
• W2280772307 cites W1557751615 @default.
• W2280772307 cites W1715337272 @default.
• W2280772307 cites W1842289770 @default.
• W2280772307 cites W1978403884 @default.
• W2280772307 cites W1982403556 @default.
• W2280772307 cites W1993698916 @default.
• W2280772307 cites W2002531179 @default.
• W2280772307 cites W2005118324 @default.
• W2280772307 cites W2010886407 @default.
• W2280772307 cites W2014932693 @default.
• W2280772307 cites W2022733790 @default.
• W2280772307 cites W2023805473 @default.
• W2280772307 cites W2032679355 @default.
• W2280772307 cites W2033959983 @default.
• W2280772307 cites W2041579383 @default.
• W2280772307 cites W2047510249 @default.
• W2280772307 cites W2052812111 @default.
• W2280772307 cites W2070410416 @default.
• W2280772307 cites W2091100179 @default.
• W2280772307 cites W2115914792 @default.
• W2280772307 cites W2126092603 @default.
• W2280772307 cites W2128437964 @default.
• W2280772307 cites W2156898263 @default.
• W2280772307 cites W2162872208 @default.
• W2280772307 cites W2398089962 @default.
• W2280772307 cites W2614634011 @default.
• W2280772307 cites W4292189154 @default.
• W2280772307 cites W84806767 @default.
• W2280772307 doi "https://doi.org/10.2147/ccid.s95108" @default.
• W2280772307 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4770068" @default.
• W2280772307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26966384" @default.
• W2280772307 hasPublicationYear "2016" @default.
• W2280772307 type Work @default.
• W2280772307 sameAs 2280772307 @default.
• W2280772307 citedByCount "19" @default.
• W2280772307 countsByYear W22807723072016 @default.
• W2280772307 countsByYear W22807723072017 @default.
• W2280772307 countsByYear W22807723072018 @default.
• W2280772307 countsByYear W22807723072019 @default.
• W2280772307 countsByYear W22807723072020 @default.
• W2280772307 countsByYear W22807723072021 @default.
• W2280772307 countsByYear W22807723072022 @default.
• W2280772307 countsByYear W22807723072023 @default.
• W2280772307 crossrefType "journal-article" @default.
• W2280772307 hasAuthorship W2280772307A5047924703 @default.
• W2280772307 hasAuthorship W2280772307A5073974786 @default.
• W2280772307 hasAuthorship W2280772307A5077591603 @default.
• W2280772307 hasAuthorship W2280772307A5090532833 @default.
• W2280772307 hasBestOaLocation W22807723071 @default.
• W2280772307 hasConcept C105702510 @default.
• W2280772307 hasConcept C142724271 @default.
• W2280772307 hasConcept C153911025 @default.
• W2280772307 hasConcept C185592680 @default.
• W2280772307 hasConcept C189165786 @default.
• W2280772307 hasConcept C202751555 @default.
• W2280772307 hasConcept C2777459323 @default.
• W2280772307 hasConcept C2777529286 @default.
• W2280772307 hasConcept C2778005187 @default.
• W2280772307 hasConcept C2779869378 @default.
• W2280772307 hasConcept C2780381497 @default.
• W2280772307 hasConcept C53227056 @default.
• W2280772307 hasConcept C54355233 @default.
• W2280772307 hasConcept C55493867 @default.
• W2280772307 hasConcept C71924100 @default.
• W2280772307 hasConcept C86803240 @default.
• W2280772307 hasConcept C98274493 @default.
• W2280772307 hasConceptScore W2280772307C105702510 @default.
• W2280772307 hasConceptScore W2280772307C142724271 @default.
• W2280772307 hasConceptScore W2280772307C153911025 @default.
• W2280772307 hasConceptScore W2280772307C185592680 @default.
• W2280772307 hasConceptScore W2280772307C189165786 @default.
• W2280772307 hasConceptScore W2280772307C202751555 @default.
• W2280772307 hasConceptScore W2280772307C2777459323 @default.
• W2280772307 hasConceptScore W2280772307C2777529286 @default.
• W2280772307 hasConceptScore W2280772307C2778005187 @default.
• W2280772307 hasConceptScore W2280772307C2779869378 @default.
• W2280772307 hasConceptScore W2280772307C2780381497 @default.
• W2280772307 hasConceptScore W2280772307C53227056 @default.
• W2280772307 hasConceptScore W2280772307C54355233 @default.
• W2280772307 hasConceptScore W2280772307C55493867 @default.
• W2280772307 hasConceptScore W2280772307C71924100 @default.
• W2280772307 hasConceptScore W2280772307C86803240 @default.
• W2280772307 hasConceptScore W2280772307C98274493 @default.
• W2280772307 hasLocation W22807723071 @default.
• W2280772307 hasLocation W22807723072 @default.
• W2280772307 hasLocation W22807723073 @default.
• W2280772307 hasLocation W22807723074 @default.

• next